Ken Okabayashi

1.1k citations
54 papers · 894 indexed · h-index 16
Topics
Fungal Infections and Studies (7 papers)Nail Diseases and Treatments (6 papers)Antifungal resistance and susceptibility (6 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEOncogene

In The Last Decade

Ken Okabayashi

52 papers receiving 872 citations

Peers

Ken Okabayashi
Comparison fields: 5 of 97
  • Molecular Biology 485
  • Epidemiology 197
  • Oncology 137
  • Cancer Research 120
  • Cell Biology 119
Replace Ravi Sirdeshmukh with:
Ravi Sirdeshmukh India
M J Yezzi United States
Badal C. Roy United States
Akihisa Tsutsumi Japan
W. Held United States
Chan Gao Canada
Phillip A. Dumesic United States
Randall H. Renegar United States
Reena Rani United States
Zhenwei Zhang China
Ken Okabayashi relative to Ravi Sirdeshmukh India Ravi Sirdeshmukh's profile →
Citations per field
00.5×1.7×
Ravi Sirdeshmukh · 1×
Citations per year

Countries citing papers authored by Ken Okabayashi

Since Specialization
Citations

This map shows the geographic impact of Ken Okabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Okabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Okabayashi more than expected).

Fields of papers citing papers by Ken Okabayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Okabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Okabayashi. The network helps show where Ken Okabayashi may publish in the future.

Co-authorship network of co-authors of Ken Okabayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Okabayashi. A scholar is included among the top collaborators of Ken Okabayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Okabayashi. Ken Okabayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 1
5 45
6 20
7 10
8 7
9 1
10 8
11 20
12 7
13 12
14 28
15 5
16 251
17 20
18 5
19 6
20 6

About Ken Okabayashi

Ken Okabayashi is a scholar working on Cell Biology, Infectious Diseases and Cancer Research, having authored 54 papers that have together received 894 indexed citations. Recurring topics across this work include Fungal Infections and Studies (7 papers), Nail Diseases and Treatments (6 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Cancer Research (120 citations), Cell Biology (119 citations) and Molecular Biology (485 citations). Ken Okabayashi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Chikara Miyamoto, Keiji Tanaka, Seishi Kato, Tomoki Chiba, Fumio Osaka, Naoki Shimbara, Takanori Narita, T. Hori, Atsuhiko Hasegawa and Hiroshi Sugiya. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026